Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for Chronic Foot Ulcers in Type 2 Diabetes
NCT01472432Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- May 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Placebo with Vildagliptin (2 arms). Primary endpoints: Full Epithelialization of the Wound at 3 months and Capillary Density at 3 months. Started May 2011; status: completed.
02
Drugs
vildagliptin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01472432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472432.